Company intelligence / Profile preview

Goldstone Investment

Grand Cayman, Cayman Islands

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Goldstone Investment Group Limited is a Cayman Islands-incorporated investment holding company listed on the Hong Kong Stock Exchange (HKEX:901), primarily focused on securities investments. It is not a life science/biotech/pharma operating company and has no active drug pipeline or clinical programs. The company reported net liabilities of HK$90M as of Dec 2022 and is managing liquidity through bond restructurings.

Industry: Investors

Beyond the preview

Go deeper on Goldstone Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goldstone Investment.

Explore the full profile